Creoptix
Creoptix develops optical instruments and consumables for the label-free analysis of molecular interactions for the drug discovery industry.
Creoptix has raised €7.2M across 1 funding round from 1 investor, most recently a Series C round in Jul 2019. Based in Wadenswil, Switzerland; founded 2009; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€7.2M
€7,203,962
Funding rounds
1
Investors
1
distinct backers
Active since
2019-07
latest 2019-07
Funding by year
EUR raised per yearCreoptix — funding by year — interactive chart.
Data table
| Creoptix — funding by year | |
|---|---|
| 2019 | €7.2M |
Signals
High confidenceRaise-next likelihood9
base rate 50% for Series C
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2019-07-01 | Series C | €7.2M | Zürcher Kantonalbank (ZKB) | View deal → |
Investors
1Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Climeworks€919MSwitzerland · Cleantech
Global coverage: FundingData